共 43 条
[1]
Ayyala RS(2017)Practical use and pitfalls of hepatocyte-specific contrast agents (HSCAs) for pediatric hepatic and biliary magnetic resonance imaging Abdom Radiol (NY) 42 502-520
[2]
Anupindi SA(2011)Characterization of pediatric liver lesions with gadoxetate disodium Pediatr Radiol 41 1183-1197
[3]
Callahan MJ(2013)Comparison of acute transient dyspnea after intravenous administration of gadoxetate disodium and gadobenate dimeglumine: effect on arterial phase image quality Radiology 266 452-461
[4]
Meyers AB(2015)Gadoxetic acid-induced acute transient dyspnea: the perspective of Japanese radiologists Magn Reson Med Sci 14 163-164
[5]
Towbin AJ(2017)Transient Severe Motion Artifact Related to Gadoxetate Disodium-Enhanced Liver MRI: frequency and Risk Evaluation at a German Institution Rofo 189 651-660
[6]
Serai S(2016)An Investigation of Transient Severe Motion Related to Gadoxetic Acid-enhanced MR Imaging Radiology 279 93-102
[7]
Davenport MS(2015)Respiratory motion artefacts in dynamic liver MRI: a comparison using gadoxetate disodium and gadobutrol Eur Radiol 25 3207-3213
[8]
Viglianti BL(2014)Matched within-patient cohort study of transient arterial phase respiratory motion-related artifact in MR imaging of the liver: gadoxetate disodium versus gadobenate dimeglumine Radiology 272 123-131
[9]
Al-Hawary MM(2019)Respiratory motion in children and young adults undergoing liver magnetic resonance imaging with intravenous gadoxetate disodium contrast material Pediatr Radiol 49 1171-1176
[10]
Motosugi U(2017)Intravenous Gadoxetate Disodium Administration Reduces Breath-holding Capacity in the Hepatic Arterial Phase: a Multi-Center Randomized Placebo-controlled Trial Radiology 282 361-368